Harrow, Inc. (HROW) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in United States, listed on NasdaqGM. Market cap 1.14B USD. 52-week range 28.54 to 54.85 USD. Data as of 2026-10-09.
Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments. The company offers ImprimisRx, an ophthalmology-focused compounded medications. It also provides IHEEZO, a chloroprocaine hydrochloride ophthalmic gel; ophthalmic solutions, including IOPIDINE, VEVYE, and ZERVIATE, as well as BYQLOVI; MAXITROL eye drops; ILEVRO and NEVANAC, a ...